PNOC 001: Phase II Study of Everolimus for Recurrent or Progressive Low-grade Gliomas in Children
Clinical trial NCT01734512 · COMPLETED
Trial details
- NCT number
- NCT01734512
- Sponsor
- University of California, San Francisco
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-13
- Primary completion
- 2020-01-31
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.